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Abstract
Background:  Copy number variants (CNVs) have been identified in several studies to be
associated with complex diseases. It is important, therefore, to understand the distribution of
CNVs within and among populations. This study is the first report of a CNV map in African
Americans.
Results: Employing a SNP platform with greater than 500,000 SNPs, a first-generation CNV map
of the African American genome was generated using DNA from 385 healthy African American
individuals, and compared to a sample of 435 healthy White individuals. A total of 1362 CNVs were
identified within African Americans, which included two CNV regions that were significantly
different in frequency between African Americans and Whites (17q21 and 15q11). In addition, a
duplication was identified in 74% of DNAs derived from cell lines that was not present in any of the
whole blood derived DNAs.
Conclusion: The Affymetrix 500 K array provides reliable CNV mapping information. However,
using cell lines as a source of DNA may introduce artifacts. The duplication identified in high
frequency in Whites and low frequency in African Americans on chromosome 17q21 reflects
haplotype specific frequency differences between ancestral groups. The generation of the CNV
map will be a valuable tool for identifying disease associated CNVs in African Americans.
Background
Duplications or deletions of genomic segments generate
copy number variants (CNVs) that can range is size from
one thousand to several million base pairs, and may affect
one or more genes. More nucleotides appear to be affected
by CNVs than by single nucleotide polymorphisms
(SNPs) [1]. Current annotated CNVs cover about 28.8%
of the genome, and, to date, over 5600 non-overlapping
human CNV loci have been identified http://
projects.tcag.ca/variation; Database of Genomic Variants)
[2]. CNVs are a major source of human genetic diversity,
and have been shown to influence rare genomic disorders
[3] as well as complex traits and diseases [4].
In addressing the role of CNVs in disease, it is important to
understand their distribution in the population at large [5].
Several studies have attempted to characterize CNVs in the
general population using data from the International Hap-
Map Consortium [1,6-8], and other reference groups
[2,5,9-11], and have confirmed that CNVs are widespread
throughout the genome but show a broad range in popula-
tion frequencies. However, as of the preparation of this
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manuscript, no reported studies have surveyed CNVs in
African Americans. The objectives of the current study are to
use genome-wide SNP array data to generate a CNV map of
the African American genome and to describe differences
between African and European Americans.
Methods
Experimental Populations
DNAs of 435 healthy African Americans and 435 healthy
individuals of European descent (hereafter referred to as
Whites) were available for analysis. High molecular weight
DNA was extracted from freshly isolated peripheral blood
lymphocytes using a standard desalting procedure. Quality
and quantity of each genomic DNA sample was evaluated
by fluorometry (Molecular Devices Spectra Max). One hun-
dred forty of the African American DNA samples were
derived from lymphoblastoid cell lines, all of which were
from females, and all other DNA was isolated from whole
blood. Epstein Bar virus (EBV)-transformed lymphoblast-
oid lines were generated from freshly isolated peripheral
blood lymphocytes. Cells were washed and resuspended in
complete Iscoves modified Dulbeccos culture media sup-
plemented with 10% v/v fetal bovine serum, antibiotics,
and virus. The ATCC B95-8 EBV-infected marmoset cell line
was used as the source for virus stocks. The UCSF institu-
tional review board approved this study and all participants
gave written informed consent.
African American individuals were recruited from 28 US
States, the mean age at sample acquisition was 45 years,
and the population displayed a wide range of admixture
[12]. African American ancestry was self reported, but Euro-
pean ancestry was documented in the majority of individu-
als based on genotyping of 186 SNPs highly informative for
African versus European ancestry as previously described
[13]. Global estimation of European ancestry using these
markers indicated 23 ± 15% European ancestry [14]. White
individuals originated from 8 different regions: Australia (n
= 11), East Europe (n = 22), North Africa (n = 1), North
America (n = 29), North Europe (n = 93), South America (n
= 1), South Europe (n = 71), and West Europe (n = 207).
Females constituted 64% and 51% of the African American
and White populations, respectively. All individuals were
assayed on the Affymetrix GeneChip® Human Mapping
500 K Array Set. Quality control filtering and SNP frequen-
cies are reported elsewhere [12].
Data Analysis
Fifty randomly chosen African American females with
DNA derived from whole blood were used as references
for calculating the normalized total intensity measures for
each SNP (log-R ratios) for all of the remaining individu-
als. The reference individuals were excluded from further
analysis, resulting in 385 African American and 435 White
test individuals. Using only female references allows the
estimation of X chromosome CNVs in female test individ-
uals. Raw copy number files (".cnchp" files) were gener-
ated using the CNAT4.0.1 algorithm in the Affymetrix®
Genotyping Consol™ 2.1 with default settings. The
".cnchp" files from both the African American and White
individuals were read into the Nexus 3.0 copy number
analysis program (BioDiscovery, Inc.) and copy number
variable regions were called using BioDiscovery's rank seg-
mentation algorithm [15] with default settings for the
Affymetrix 500 K assay which requires at least one probe
per segment. CNV frequencies and between group fre-
quency differences were estimated using Nexus. Fisher's
Exact test was used to determine the significance of the fre-
quency differences and False Discovery Rate (FDR) [16]
was used to correct for multiple comparisons.
qPCR
CNVs of interest were validated using region-specific Taq-
Man assays. An internal positive control gene (β-globin,
HBB) was included in each assay to determine copy
number and to confirm that the reaction amplified suc-
cessfully [see Additional file 1]. Threshold cycle (Ct) val-
ues were generated from a pre-established threshold and
ΔCt values were estimated from the difference of the con-
trol gene and the CNV test region. The ΔCt values were
then treated as a quantitative trait and standard analysis of
variance was utilized to test the association of the SNP-
determined CNV status with the ΔCt for that region.
Results
DNAs from 385 healthy African American and 435 healthy
White individuals were scanned using the Affymetrix Gene-
Chip® Human Mapping 500 K Array Set to identify CNVs. A
single African American individual's DNA was plated twice,
and is used as a comparison for consistency for CNV calls
using the Affymetrix 500 K platform. Based on the log-R
ratios, evidence for four identical CNVs was present in both
samples, although a single deletion on chromosome 21
identified in one sample was just below the call threshold
in the other sample [see Additional file 2]. The consistency
of the results indicates the reproducibility of the experi-
ment, albeit only in a single sample.
Based on the distribution of the number of CNV calls per
individual [see Additional file 3], 28 individuals were
identified as outliers (due to high numbers of CNV calls)
and removed from the analysis to reduce the probability
of CNV calls that were a result of assay performance rather
than the presence of true CNVs. In addition, all CNVs on
the X chromosome identified in males were removed,
since all males have deletions of a single copy of the X
chromosome when compared to female references.
Autosomal CNVs were contrasted between African Ameri-
can males and females to establish a conservative thresh-
old for the largest CNV frequency differences expected
under the null hypothesis, since true autosomal differ-BMC Genetics 2009, 10:15 http://www.biomedcentral.com/1471-2156/10/15
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ences between males and females are not expected. The
largest frequency difference for any autosomal CNV
between African American males and females was 6.6%.
Performing the same experiment in Whites yielded a larg-
est autosomal CNV frequency difference between males
and females of 5%. None of the CNV regions in either
group with a frequency difference of 5% or greater
between males and females harbored genes that were
obvious candidates for sexual dimorphism. Since the larg-
est frequency difference observed between males and
females was 6.6%, a conservative threshold of 10% will be
used in combination with the Fisher's Exact test FDR cor-
rected p-values to declare true differences for further com-
parisons.
While all of the DNA samples for the White individuals
were isolated from whole blood, 140 of the African Amer-
ican DNAs were isolated from lymphoblastoid cell lines.
DNA derived from cell lines may have CNVs that result
from the establishment of the lines [17]. Any high fre-
quency CNVs in the African American group that arose
from the process of creating cell lines need to be identified
and removed from the comparison between African and
Whites. Considering only African American subjects, three
regions showed a significant difference greater than 10%:
chromosome 14 (21,811,993 – 21,836,082) (duplication
in 74% of cell line DNAs; FDRp < 0.001), chromosome 14
(105,619,582 – 106,173,672) (deletion in 10.7% of cell
line DNAs; FDRp < 0.001), and chromosome 17
(41,592,674 – 41,597,102) (duplication in 11.03% of cell
line DNAs; FDRp < 0.002). CNVs in cell lines in these
regions will not be considered in further comparisons
between African American and White CNVs.
CNV Detection
In the 384 African Americans, a total of 1362 copy number
events were identified, with a mean of 3.5 CNVs per individ-
ual vs. the reference panel (results for DNAs isolated from
whole blood are shown in Figure 1A). A total of 1972 copy
number events were identified in Whites, resulting in a mean
of 4.8 CNVs per individual. The higher CNV frequency in
Whites (Wilcoxon rank-sum test p < 0.0001) was not surpris-
ing since the reference group consists of African American
genomes. The average size of duplications and deletions in
African Americans were 827 kb and 703 kb, respectively
(Wilcoxon rank-sum test p = 0.031), and the average size of
duplications and deletions in Whites were 671 kb and 708
kb, respectively (Wilcoxon rank-sum test p < 0.0001).
Counting each CNV region as a different feature unless both
borders were identical (border-matched), 1068 CNV regions
were identified across all individuals. For these border-
matched CNV regions, 412 were unique to African Ameri-
cans, 580 were unique to Whites, and 76 were common
between the two populations. Excluding CNVs that occurred
only in a single individual, 27 were unique to African Amer-
icans, 71 were unique to Whites, and 76 were common [see
Additional file 4]. The highest frequency CNV regions iden-
tified in African Americans were duplications on chromo-
somes 9 and 15 (15: 30.83%; 19,643,165 – 19,978,503).
The duplication on chromosome 9 was divided into three
sections (41,217,099 – 46,875,500) separated by segments
without SNPs (the two flanking segments were tagged only
with single SNP because there were no other SNPs in the
immediate vicinity), and therefore is likely a single CNV.
Across this region, the highest frequency of the duplication
in the African American population was 48.7%. One of the
chromosome 9 single SNP tagged-CNVs is in a region not
identified in the Database of Genomic Variants. In addition,
a CNV region on chromosome 5 (162,208,673 –
162,463,912) was identified in two African American indi-
viduals that was not in the Database of Genomic Variants.
All other African American CNVs identified in two or more
individuals overlapped at least partially with regions
denoted as CNVs in the Database of Genomic Variants [2].
Two regions were markedly different between African
Americans and Whites, excluding cell line regions (Figure
1B and 1C). A duplicated region was identified on chro-
mosome 17 (41,600,030 – 41,932,225) that had a fre-
quency of 45.1% in Whites and 8.03% in African
Americans (FDRp < 0.001). Two genes are annotated in
this region: leucine rich repeat containing 37A (LRRC37A)
and ADP-ribosylation factor-like 17 (ARL17). Another
duplicated region was identified on chromosome 15
(19,212,556 – 19,400,776) with a frequency of 21.24% in
African Americans and 40.69% in Whites (FDRp < 0.001).
The gene ANKRD26-like family B, member 1 (A26B1) is
in this region. None of the aforementioned genes appear
to have a readily identifiable biological association with
ethnic differences. All other CNV features had a difference
of <10% between African Americans and Whites.
Extreme copy events (homozygous deletions and >1 copy
gains) were also analyzed independently from the previ-
ous analysis for differences between the two populations.
In total, 75 extreme copy events were identified in African
Americans (70 gains and 5 losses) and 176 extreme copy
events were identified in Whites (171 gains and 5 losses).
None of the frequencies of the extreme copy event regions
were greater than 10% different between African Ameri-
cans and Whites, but a single region was significantly dif-
ferent (p < 0.05) after FDR correction on chromosome 15
(18,427,103 – 19,643,166). This multiple copy gain in
this region had a maximum frequency of 0.013 in African
Americans and 0.086 in Whites. The two genes located in
this region (coxsackie virus and adenovirus receptor pseu-
dogene 2 [CXADRP2] and POTE ankyrin domain family
member B [POTEB]) do not have an immediately appar-
ent functional association with ethnicity.
In addition to the cell line associated CNV regions identi-
fied in the current study, copy number variations of chro-BMC Genetics 2009, 10:15 http://www.biomedcentral.com/1471-2156/10/15
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mosome 2 (88,876,198–89,912,849; 0.093 frequency in
cell line derived DNAs and 0.024 frequency in whole
blood derived DNAs), and deletions of chromosome 22
(20,905,109–21,439,970; 0.029 frequency in cell line
derived DNAs and 0 frequency in whole blood derived
DNAs) have previously been shown to be artifacts of
transformation or somatic recombination of immu-
noglobulin genes ([17] and [18], respectively). Although
these regions did not meet the criteria (FDR significant
and >10% frequency difference) to be identified as associ-
ated with the generation of cell lines in the current study,
they will be excluded from the data submitted to the Data-
base of Genomic Variants, as will three regions labeled as
copy number variant based on the data from a single SNP
(because of sparse SNP spacing in these regions). All other
CNVs identified the current study have been submitted to
the Database of Genomic Variants [2].
qPCR
In order to assess the robustness of the Affymetrix 500 K
array to identify CNVs, qPCR was performed in a subset of
the African American samples on three representative
CNV regions, selected based on the frequency differences
between the two populations (chromosomes 15 and 7)
and the differences between cell lines and blood (chromo-
some 14). Although it did not reach the 10% difference
threshold, the chromosome 7 region (76,052,765 –
76,371,008) (FDRp < 0.001) was chosen over the chro-
mosome 17 region because there were more African
Americans with the chromosome 7 CNV. In addition,
both cell line and blood-derived DNAs were included for
ten individuals with the chromosome 14 duplication. Fig-
ure 2 depicts the graphs of the ΔCt values for each of the
ANOVA comparisons. In every case, the mean of the ΔCt
was in the expected direction, confirming the presence of
Distribution of CNVs and differences in CNV frequencies Figure 1
Distribution of CNVs and differences in CNV frequencies. A. Genomic distribution of CNV frequencies in the African 
American population. Green bars above the central line indicate duplications at those genomic positions and red bars below the 
central line indicate deletions at those genomic positions. The height of the bars indicate the frequency of the CNV at a given 
genomic position in the population. B. Genomic distribution of CNV frequency differences between whole blood derived African 
American and White DNAs. A green or red bar above the central line indicates a higher frequency of duplications or deletions, 
respectively, in the whole blood DNA at the given genomic position, and the height of the bar indicates the magnitude of those 
frequency differences. Likewise, bars below the central line indicate higher frequencies in cell line DNAs. C. Close up of differ-
ences of CNV frequencies between African Americans and Whites for the chr. 15q11 and 17q21 regions. Green line below the 
central line indicates and increased frequency of duplication in Whites, and above in African Americans. Red line below the central 
line indicates and increased frequency of deletion in African Americans, and above in Whites. The lines below the chromosomal 
graph indicate the gene locations and locations of CNVs in the Database of Genomic Variants (pink bar).BMC Genetics 2009, 10:15 http://www.biomedcentral.com/1471-2156/10/15
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Delta ct distributions for ANOVA of three CNVs validated by qPCR Figure 2
Delta ct distributions for ANOVA of three CNVs validated by qPCR. P-values for ANOVAs were p = 0.00001 (Chr. 
7q11), p = 0.0001 (15q11), and p = 1.2e-12 (14q11). Lower delta ct values indicate higher copies. Green lines indicate means, 
blue lines indicate standard deviations. Primer sequences for the three CNV regions: chromosome 7 forward-5' TGC CAC 
TTG CGT TCT T 3', reverse-5' CTT GGG CCA CGT CAT T 3'; chromosome 14 forward-5' CAC TGG CAT TTG GTA 
TCG T 3', reverse-5' CCC AAA GTG AAA CGT ATT 3'; chromosome 15 forward-5' ATG CCA CAT ATT CTT ACT CAT 
3', reverse-5' CCA CAC TCC ACC CTC AA 3'.BMC Genetics 2009, 10:15 http://www.biomedcentral.com/1471-2156/10/15
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the CNVs, i.e., the higher the number of copies indicated
by the SNP analysis for a region, the lower the mean ΔCt
value for that group. In addition, for each of the ten indi-
viduals in which cell line and blood derived DNAs were
included, the cell line DNAs had a lower ΔCt than the
whole blood DNAs for the chromosome 14 duplication,
indicating that indeed there were more copies of the
region in the cell line DNAs [see Additional file 5].
Discussion
In the current study, a CNV map was generated using DNA
from a population of 385 African Americans using 50 ran-
domly chosen female African Americans as a reference. A
total of 1362 CNV events were identified in the popula-
tion. In addition, CNVs were identified in a population of
435 White individuals using the same 50 African Ameri-
can females as a reference. The same reference population
was used so that the CNV distributions of the two popula-
tions would be directly comparable. Two regions of the
genome exhibited large CNV frequency differences
between the two populations, one on chromosome 15
and another on chromosome 17. No genes in these
regions had obvious roles in ethnic differences.
A total of 140 of the African American DNAs were derived
from cell lines. The process of creating the cell lines gener-
ated a duplication on chromosome 14 in 74% of the cell
line-derived DNAs. Although this region is listed as copy
number variant in the Database of Genomic Variants,
none of the DNAs derived from whole blood was identi-
fied as having this duplication. Apparently, either trans-
fection with the EBV virus or the growing out of the cells
caused this duplication event. The EBV virus may have
integrated into this site, disrupting the organization of the
region and resulting in the duplication. However, Jeon
and colleagues did not identify a CNV in this region
resulting from EBV transformation of B-cells from Korean
subjects, and the 1p36.33 copy number increase identi-
fied in cell lines by Jeon et. al was only found in a cell line
from a single individual in the current study [17]. Simon-
Sanchez and colleagues also did not identify this CNV
when comparing DNA from EBV transformed cell lines to
blood derived DNAs in a cohort of North American
Whites [19]. Another possibility is that the integration of
the EBV DNA into another site of the genome may facili-
tate duplication at this site. Finally, a gene in this region
may facilitate the process of expansion or survival of the
cell line, and therefore cells with this duplication may
have been selected for in the culturing and growing proc-
ess. However, there are no annotated genes in the region
of the duplication. Currently, it is unknown if the dupli-
cation is an ethnic, experimental, or EBV strain specific
phenomenon, and the determination of these specifics is
under investigation.
A duplication on chromosome 17 (41,600,030 –
41,932,225) was identified in both African Americans and
Whites in the current study. This duplication is in the
same location as a segmental duplication flanking a men-
tal retardation associated deletion identified in another
study [20]. Segmental duplications have been shown to
be catalysts for chromosomal rearrangement [10]. Two
major haplotypes (H1 and H2) are present in this region
of the human genome, and the ancestral haplotype (H2),
which is more prone to duplications, is found mostly in
people of European descent (see [21] for discussion of
17q21.31). Most Africans have the H1 haplotype, which
may explain the large frequency difference of the duplica-
tion in this genomic region between African Americans
and Whites. Since the present study found that the dupli-
cation was present in 45% of Whites and only 8% of Afri-
can Americans, it will be of interest to assess if the severe
neurological phenotype resulting from the deletion in the
17 region is more prevalent in Whites than in Africans or
African Americans. CRHR1 (corticotrophin releasing hor-
mone receptor 1) and MAPT (microtubule-associated pro-
tein tau) are two of the six genes within the region deleted
as a result of the segmental duplication. These genes are
both associated with many neurological disorders. Since it
is close to the genes, it is important to determine whether
the duplication has an effect on the expression of these
genes, which could produce a neurological phenotype.
Conclusion
As of the preparation of this manuscript, there are no
other reports of the production of a CNV map in African
Americans. The creation of this map is an important first
step in determining the presence CNV admixture in Afri-
can Americans. Since many studies are now identifying
CNVs as underlying causes in disease subsets, the African
American CNV map will also be important for identifying
cross-ethnic and ethnic-specific disease associated CNVs.
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Replication of CNV analysis in a single individual. A. CNV calls in 
replicate individual. A green bar above the line for an individual indicates 
a duplication at that region in the genome, and a red bar below indicates 
a deletion at that region in the genome. B. Log R ratios for SNPs on chro-
mosome 21. Arrows indicate the region designated as deleted in the first 
replicate, but not in the second replicate.
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Additional file 3
Distribution of the numbers of CNV calls per individual before (A) 
and after (B) removing outliers. The upper panels of each figure are box 
and whiskers plots of the data. Each box indicates the interquartile range, 
each line across the boxes indicates the median, the diamonds indicate the 
means and 95% confidence intervals, and the whiskers indicate the upper 
quartile + 1.5 × interquartile range (right side of boxes) and the lower 
quartile – 1.5 × interquartile range (left side of boxes).
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[http://www.biomedcentral.com/content/supplementary/1471-
2156-10-15-S3.doc]
Additional file 4
CNVs identified in more than a single individual. Location, types of 
CNV events, and within population frequencies of CNVs identified in two 
or more individuals. Events (relative to reference population): HDel = two 
copies decrease, Del = one copy decrease, Dup = one copy increase, HDup 
= two or more copy increase.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2156-10-15-S4.doc]
Additional file 5
qPCR of chr. 14 replicates (red cell line, blue whole blood). Bar chart 
of delta Cts for ten individuals with both whole blood and cell line derived 
DNAs for the chromosome 14q11 cell line associated CNV. Red bars are 
cell line DNAs, blue bars are whole blood DNAs. In every individual, the 
cell line DNAs have a lower delta Ct. Primer sequence for chromosome 14 
qPCR: forward-5' CAC TGG CAT TTG GTA TCG T 3', reverse-5' CCC 
AAA GTG AAA CGT ATT 3'.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2156-10-15-S5.doc]